One-day intensified lansoprazole-quadruple therapy for cure of Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 1, 1997, Pages 109-112

  De Boer, W A ^a   Van Etten, R J X M ^a   Schade, R W B ^a   Ouwehand, M E ^a   Schneeberger, P M ^a   Van Unnik, A J M ^a   Tytgat, G N J ^b  

^a ST ANNA HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH CITRATE; LANSOPRAZOLE; METRONIDAZOLE; TETRACYCLINE;

ADULT; AGED; ARTICLE; BIOPSY; CLINICAL ARTICLE; DRUG EFFICACY; DRUG RESISTANCE; ENDOSCOPY; FEMALE; HELICOBACTER PYLORI; HUMAN; MALE; PEPTIC ULCER; PRIORITY JOURNAL; SIDE EFFECT; ULCER HEALING;

EID: 0031033580     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.121292000.x     Document Type: Article

References (36)

1. National Institutes of Health consensus conference: Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994: 272: 65-9.
2. Soll AH. Consensus statement. Medical treatment of peptide ulcer disease. Practice guidelines. J Am. Med Assoc 1996; 275: 622-9.
3. van der Hulst RWM, Keller JJ, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection in humans: A review of the world literature. Helicobacter 1996; 1: 6-19.
4. Treiber G. The influence of drug dosage on Helicobacter pylori eradication: a cost-effectiveness analysis. Am J Gastroenterol 1996; 91: 246-57.
5. de Boer WA, Tytgat GNJ. The best therapy for Helicobacter pylori infection: should efficacy or side effect profile determine our choice? Scand J Gastroenterol 1995; 30: 401-7.
6. Thys JC, Kuipers EJ, van Zwet AA, Pena AS, de Graaf J. Treatment of Helicobacter pylori infections. Q J Med 1995; 88: 369-89.
7. Hentschel E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993: 328-308-12.
8. Gisbert JP, Boixeda D, Martin de Argilla C. Response to article by Forne et al. Am J Gastroenterol 1996; 91: 176-7 (Letter).
9. Hosking SW, Ling TKW, Yung MY, et al. Randomised controlled trial of short term treatment to eradicate H. pylori in patients with duodenal ulcer. Br Med J 1992; 305: 502-4.
10. O'Connor HJ, Kanduru C, Bhutta AS, et al. Effect of Helicobacter pylori eradication on peptic ulcer healing. Postgrad Med J 1995; 71: 90-3.
11. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994; 331: 717-27.
12. Daneshmend TK, Hawkey CJ, Langmann MJS, Logan RFA, Long RG, Walt RP. Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double line controlled trial. Br Med J 1992; 304: 143-7.
13. 90% cure: Which anti-Helicobacter therapy can achieve this treatment goal? Am J Gastroenterol 1995; 90: 1381-2 (Editorial).
14. de Boer WA, Driessen WMM, Jansz AR, Tytgat GNJ. Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study. Eur J Gastroenterol Hepatol 1995; 7: 1189-94.
15. de Boer WA, Driessen WMM, Jansz AR, Tytgat GNJ. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345: 817-20.
16. Hosking SW, Ling TKW, Chung SCS, et al. Duodenal ulcer healing by eradication of H. pylori without anti-acid treatment: randomised controlled trial. Lancet 1994; 343: 508-10.
17. Sung JJY, Leung VKS, Chung SCS, et al. Triple therapy with sucralfate, tetracycline and metronidazole for Helicobacter associated duodenal ulcers. Am J Gastroenterol 1995; 90: 1424-7.
18. Borody TJ, Andrews P, Shortis NP, Hyland L. Seven day therapy for Helicobacter pylori. Gastroenterology 1995; 108: A62 (Abstract).
19. de Boer WA, van Etten RJXM, Lai JYL, Schneeberger PM, van der Wouw BAM, Driessen WMM. Effectiveness of 7 day quadruple therapy using lansoprazole instead of omeprazole in curing Helicobacter pylori infection. Helicobacter 1996; 7: 145-50.
20. de Boer WA, Driessen WMM, Tytgat GNJ. Only four days of quadruple therapy can effectively cure Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9: 633-8.
21. de Boer WA, van Etten RJXM, Schade RWB, Ouwehand ME, Schneeberger PM, Tytgat GNJ. Four day lansoprazole quadruple therapy is very effective in curing Helicobacter pylori infection. Am J Gastroenterol 1996; 91: 1778-82.
22. Tucci A, Poli L, Mazzoni C, et al. Weekend therapy for H. pylori eradication. Gastroenterology 1995; 108: A246 (Abstract).
23. Kimura K, Ido K, Saifuku K, et al. A 1-h topical therapy for the treatment of Helicobacter pylori infection. Am J Gastroenterol 1995; 90: 60-3.
24. de Boer WA, Thys JC, Borody TJ, Graham DY, O'Morain C, Tytgat GNJ. Proposal for use of a standard side effect scoring system in studies exploring H. pylori treatment regimens. Eur J Gastroenterol Hepatol 1996; 8: 641-3.
25. Deskalopoulos G, Carrick, J. Lian R. Lee A. Optimising therapy for H. pylori gastritis. Ir J Med Sci 1992; 161 (Suppl. 10): 16 (Abstract).
26. Borody TJ, Andrews P, Fracchia G, Brandi S, Shortis NP, Bae, H. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995; 37: 477-81.
27. Iwahi T, Satoh H. Nakao M. et al. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 1991; 35: 490-6.
28. Megraud F, Boyanova L, Lamouliatte H. Activity of lansoprazole against Helicobacter pylori. Lancet 1991; 337: 1486 (Letter).
29. Takimoto Y, Ido K, Taniguchi Y, et al. Efficacy of lansoprazole in eradication of Helicobacter pylori. J Clin Gastroenterol 1995; 20 (Suppl. 2): S121-4.
30. Damman HG, Richter G, Wolf N, Burkhardt F. Influence of lansoprazole 15 and 30 mg and omeprazole 20 and 40 mg on meal stimulated gastric acid secretion. Gut 1995: 37 (Suppl. 2): A45-6 (Abstract).
31. Ripke H, Fuder H, Kleistl P, et al. Intragastric pH under various dosage regimens of lansoprazole as compared to a reference treatment with omeprazole. Gut 1995; 37 (Suppl. 2): A3 (Abstract).
32. de Boer WA. How to achieve a near 100% cure rate for H. pylori infection in peptide ulcer disease. J Clin Gastroenterol 1996; 22: 313-6.
33. Calam J. Clinicians' guide to Helicobacter pylori. London: Chapman & Hall, 1996.
34. Harris A, Misiewicz JJ, Hitting H. pylori for four. Lancet 1995; 345:806-7 (Editorial).
35. van Zwet AA, Thys JC, Schievink-de Vries W, Schiphuis J, Snijder JAM. In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori. Antimicrob Agents Chemother 1994; 38: 360-2.
36. Beji A, Vincent P, Darchis I, Husson MO, Cortot A, Leclerc H. Evidence of gastritis with several Helicobacter pylori strains. lancet 1989; ii: 1402-3.